DISEASE INDICATIONS: Familial chylomicronemia syndrome (FCS)
MANUFACTURER: Akcea Therapeutics Ireland Limited
USAGE: Subcutaneous
MEDICINE APPROVED BY:
European Medical Agency (EMA)
Waylivra (volanesorsen) is a prescription medication used to treat adults with genetically confirmed familial chylomicronemia syndrome (FCS) and at high risk for pancreatitis, in whom response to diet and triglyceride lowering therapy has been inadequate. FCS is a rare genetic disorder that causes the body to produce too much of a type of fat called chylomicrons. Chylomicrons can build up in the blood and cause pancreatitis, a serious inflammation of the pancreas.
